Tapentadol is partially metabolized from the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medicine that greatly enhance or repress the activity/expression of one or more of these enzymes, along with with substrates of those enzymes (resulting from competition for your enzyme); some enzyme mediators/substrates demand https://douglasv330ejk2.bimmwiki.com/user